Ecolab

ECL Q1 2026 Earnings

Reported Apr 28, 2026 at 8:06 AM ET · SEC Source

Q1 26 EPS

$1.70

BEAT +0.12%

Est. $1.70

Q1 26 Revenue

$4.07B

BEAT +0.93%

Est. $4.03B

vs S&P Since Q1 26

-6.3%

TRAILING MARKET

ECL -2.1% vs S&P +4.2%

Market Reaction

Did ECL Beat Earnings? Q1 2026 Results

Ecolab kicked off fiscal 2026 with a solid first quarter, posting adjusted diluted EPS of $1.70 against a consensus estimate of $1.70, a narrow but clean beat, while revenue climbed 10.0% year over year to $4.07 billion, edging past the $4.03 billion… Read more Ecolab kicked off fiscal 2026 with a solid first quarter, posting adjusted diluted EPS of $1.70 against a consensus estimate of $1.70, a narrow but clean beat, while revenue climbed 10.0% year over year to $4.07 billion, edging past the $4.03 billion Wall Street had anticipated. The primary engine behind the top-line strength was the combination of organic growth and contributions from the Ovivo Electronics acquisition, with standout performances in Life Sciences, which accelerated to 11% organic growth fueled by a more-than-doubling of bioprocessing sales, and Global High-Tech, which grew over 20% organically. Adjusted operating income rose 15% to $679.70 million, with margin expanding 70 basis points to 16.7%, though management flagged sharply rising commodity costs as a near-term headwind, prompting a global energy surcharge announcement. Despite the transitional pressure expected in Q2, Ecolab maintained its full-year 2026 adjusted EPS outlook of $8.43 to $8.63, representing 12%-15% growth, with organic sales growth anticipated to accelerate to 6%-7% in the second half as pricing gains momentum.

Key Takeaways

  • Strong value pricing contributing 3% organic growth
  • Accelerated volume growth of 1% driven by growth engines and new business wins
  • Growth engines collectively strengthened: Life Sciences +11%, Pest Elimination +7%, High-Tech +25% organic, Digital +24%
  • Improved productivity across segments
  • One Ecolab enterprise cross-selling growth strategy driving new business wins
  • Bioprocessing more than doubled its sales during the quarter
  • Favorable currency translation adding $0.08 per share
  • Ovivo Electronics acquisition contributing 5% to Global Water sales growth
24/7 Wall St

ECL YoY Financials

Q1 2026 vs Q1 2025, source: SEC Filings

24/7 Wall St

ECL Revenue by Segment

With YoY comparisons, source: SEC Filings

Q1 25 Q1 26

“We delivered another strong quarter, with accelerated sales growth and double-digit earnings growth reflecting the strength of our growth engines and the improving performance of our core businesses. That performance was driven by strong value pricing, accelerated volume growth and improved productivity, demonstrating the power of our technology- and service-led model and the way our teams execute every day to deliver for customers in a complex operating environment.”

— Christophe Beck, Q1 2026 Earnings Press Release